Navigation Links
New Insights into Antimalarial Drug Resistance

Researchers at Georgetown University Medical Center say they are moving closer to understanding why the most lethal form of human malaria has become resistant to drug treatment in the past three decades. They have been able to artificially construct, and then express in yeast, a protozoan gene that contributes to such resistance.

The gene they laboriously constructed over a two-year period is believed to be the largest synthetic one ever built, and it successfully produces large quantities of the encoded protein, whose function can now be easily studied.

The researchers say that with the addition of the recreated gene, PfMDR1 and its protein, they have all the biomolecular tools necessary to molecularly understand how the malarial parasite Plasmodium falciparum (P. falciparum), has become resistant to most of the drugs that could once destroy it. They have already described and expressed two other genes known to confer drug resistance.

Now that we have these genes expressed in a convenient yeast system, we can work to understand the molecular basis of anti-malarial drug resistance, providing insight into how future drugs might be designed to effectively kill the parasite, said Paul Roepe, PhD, a professor in the Department of Biochemistry and Cellular & Molecular Biology and the Department of Chemistry.

Any animal with red blood cells can develop malaria, which is caused by a single-cell protozoan parasite transmitted by the bite of the female Anopheles mosquito. There are about 160 different species of malaria parasites, according to Roepe. Five infect humans, but P. falciparum is responsible for about 1 million deaths out of 300 million acute cases of infection each year. Most of these deaths occur in young children living in sub-Saharan Africa.

Roepe and his collaborators at Georgetown University, in collaboration with investigators at the National Instit
'"/>




Page: 1 2 3 4

Related medicine news :

1. Study Offers Insights Into Treatment Of Rheumatoid Arthritis
2. Reindeer Provide Valuable Insights Into Sleep Disorders
3. Insights Into Lead Pollution
4. Insights into Osteosarcoma in Cats and Dogs may Improve Palliative Care
5. New Insights into Chronic Inflammation and Atherosclerosis
6. Neural Basis of Anxiety: Newer Insights
7. Antihistamine Could also be used as a Potential Antimalarial Drug
8. Link between birth weight and Insulin Resistance
9. Easier Methods Required to Screen Insulin Resistance
10. Easier Methods Required to Screen Insulin Resistance
11. Insulin Resistance Linked To Difference In Gender

Post Your Comments:
(Date:12/1/2009)... Amadeus will operate as a division of Xybion...lls, NJ (PRWEB) December 1, 2009 -- Xybion Corpora...uisition of all operating assets of Quebec City ba... of enterprise governance, risk, compliance and qu... a corporate performance management organization h...
(Date:12/1/2009)... Recent Reviews In Major Peer Review Journals...ising New Developments For The Evidence-Based Asse...iculties. Some Of The Most Recent Are Listed Below...009 -- Review written by: Leesa V. Huang Ph.D. for...No. 3 November 2009. A nice synopsis of this artic...
(Date:12/1/2009)... The Daniel Jordan Fiddle Foundation, a natio...p, advocate for, and support programs and services...isorders (ASD), has released a free informational ...zures: How To Recognize The Signs and Basic First... New York, NY (PRWEB) December 1, 2009 -- Statisti...
(Date:12/1/2009)...inn., Dec. 1 "The patient will see... for Blue Cross and Blue Shield of Minnesota,s 10,...he first Minnesotans - and the first in the contin...e(SM). Online Care Anywhere allows patients to acc...ng onto a computer or picking up the phone. Blue C...
(Date:12/1/2009)..., SHENZHEN, China, Dec. 1 /PRNewswire-Asia-Fi...SE: NPD ) ("Nepstar" or "the Company"), the larg...umber of directly operated stores,today announced...rter ended,September 30, 2009. ,, Financi...terminated a voting rights assignment agreement,w...
Breaking Medicine News(10 mins):Health News:Xybion Acquires Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions 2Health News:Xybion Acquires Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions 3Health News:Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV 2Health News:Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV 3Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 2Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 3Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 4Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 2Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 3Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 2Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 3Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 4Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 5Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 6Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 7Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 8Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 9Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 10Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 11Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 12Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 13
...estern University about the effects of epidural pa...at epidural analgesic given at the early stages of...n delivery. 728 pregnant ladies in their final ...s of labor tended to be in labor for less time and...
...d in traditional Indian medicine to treat diabetes...in a manner similar to prescription drugs. The ...salacia oblonga, which is native to regions of Ind..., the sugar that circulates throughout the body. I...
...ffect of diseases on contact with children it was ...s likely to get the kind of affection other kids r... HIV-positive parents report avoided certain types...en their own conditions. Researchers talked wit...
...dden emotional stress can result in severe but rev...c heart attack.// Stress cardiomyopathy is oft...According to the researchers, patients have actual...ypical heart attack including chest pain, fluid in...
...betes begins in Chennai today. The theme for the c...tions //and over 1000 doctors and researchers will...ld. The world congress for diabetes is held...three-day event that draws support from World Heal...
...dy researchers say the arthritis drug rofecoxib (V...k. For the study researchers looked at health reco...er had a heart attack when the research started. A...xicam, and the COX-2 inhibitor celecoxib (Celebrex...
Other Medicine News:
(Date:11/30/2009)... , NEW YORK, Nov. 30 Reportli...rt is available in its catalogue: ,, Outsourci...4) ,, http://www.reportlinker.com/p0165747/Ou... ,, Report Description ,, Medical devices ...ector with an estimated size of $250 billion in 20...
(Date:11/30/2009)... MT. LAUREL, N.J., Nov. 30 /PRNewswire-FirstCall...rovider of technology-enabled clinical documentati... at the Radiological Society of North America (RSN...r Radiology, the product leverages SpeechQ(TM), th...on application used by thousands of radiologists. ...
(Date:11/30/2009)..., COVINA, Calif., Nov. 30 StemCyt...ialization agreement with Academia Sinica, the Nat...y methods and Intellectual Property (IP) related t... This method and IP was pioneered by a team led b...mia Sinica. Professor Lin is currently the exclus...
Breaking Medicine Technology:Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 3Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 4Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 5Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 6Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 7Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 9MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3URAC Brings Together Leaders in Health Care Management 53052 1URAC Brings Together Leaders in Health Care Management 53052 2URAC Brings Together Leaders in Health Care Management 53052 3URAC Brings Together Leaders in Health Care Management 53052 4Globaltel Media Appoints Leading Healthcare Industry Veterans to Advisory Board 53049 1Globaltel Media Appoints Leading Healthcare Industry Veterans to Advisory Board 53049 2Globaltel Media Appoints Leading Healthcare Industry Veterans to Advisory Board 53049 3Sunesis Reports Financial Results for the Second Quarter 2009 13248 1Sunesis Reports Financial Results for the Second Quarter 2009 13248 2Sunesis Reports Financial Results for the Second Quarter 2009 13248 3Sunesis Reports Financial Results for the Second Quarter 2009 13248 4Sunesis Reports Financial Results for the Second Quarter 2009 13248 5Sunesis Reports Financial Results for the Second Quarter 2009 13248 6Sunesis Reports Financial Results for the Second Quarter 2009 13248 7Sunesis Reports Financial Results for the Second Quarter 2009 13248 8Sunesis Reports Financial Results for the Second Quarter 2009 13248 9Sunesis Reports Financial Results for the Second Quarter 2009 13248 10Sunesis Reports Financial Results for the Second Quarter 2009 13248 11
Pacemaker Follow-Up Service
PROTG® GPS™ Self-Expanding Nitinol Stent
Assay Development
Coat-Block-Run Conjugation Kit pH 8-11
Medicine Products: